Elicera Therapeutics AB (FRA:8E8) OCF Yield %: -15.06 (As of Jul. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:8E8 Elicera Therapeutics AB FRA:8E8
40 GF Score
Price €0.21
! 1 Warning Sign
View Full Analysis

What is Elicera Therapeutics AB OCF Yield %?

Elicera Therapeutics AB FRA:8E8 -3.87% 40 OCF Yield % is -15.06 as of Jul. 16, 2026. GuruFocus rates FRA:8E8 with a GF Score™ of 40/100. The stock has 1 warning sign investors should review. Among 1,410 Biotechnology companies, Elicera Therapeutics AB ranks worse than 63.33% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Elicera Therapeutics AB's Trailing 12-Month Cash Flow from Operations is €-2.55 Mil, and Market Cap is €15.75 Mil. Therefore, Elicera Therapeutics AB's OCF Yield % for today is -15.06%.

The historical rank and industry rank for Elicera Therapeutics AB's OCF Yield % or its related term are showing as below:

FRA:8E8' s OCF Yield % Range Over the Past 10 Years
Min: -15.06   Med: 0   Max: -15.06
Current: -15.06

During the past 7 years, the highest OCF Yield % of Elicera Therapeutics AB was -15.06%. The lowest was -15.06%. And the median was %.

FRA:8E8's OCF Yield % is ranked worse than
63.33% of 1410 companies
in the Biotechnology industry
Industry Median: -8.325 vs FRA:8E8: -15.06

Elicera Therapeutics AB's OCF Margin % for the quarter that ended in Mar. 2026 was %.

Elicera Therapeutics AB OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Elicera Therapeutics AB OCF Yield % Related Terms

Elicera Therapeutics AB OCF Yield % Historical Data

* Premium members only.

The historical data trend for Elicera Therapeutics AB's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elicera Therapeutics AB OCF Yield % Chart

Elicera Therapeutics AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial -14.57 -13.32 -16.22 -46.43 -8.55

Elicera Therapeutics AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.50 -8.67 -5.65 -15.99 -11.15

FRA:8E8 vs VRTX, REGN, ALNY: OCF Yield % Comparison

For the Biotechnology subindustry, Elicera Therapeutics AB's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Elicera Therapeutics AB OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Elicera Therapeutics AB's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Elicera Therapeutics AB's OCF Yield % falls into.


FRA:8E8
40GF Score
Elicera Therapeutics AB FRA:8E8
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Elicera Therapeutics AB OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Elicera Therapeutics AB's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-1.98 / 23.163045
=-8.55%

Elicera Therapeutics AB's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-0.648 * 4 / 23.2377645
=-11.15%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -15.06 mean?
Elicera Therapeutics AB (FRA:8E8) has a OCF Yield % of -15.06 as of Jul. 16, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Elicera Therapeutics AB and its competitors. According to the industry distribution chart, Elicera Therapeutics AB ranks #893 out of 1410 companies in the Biotechnology industry, placing it in the top 63.3%.
Is Elicera Therapeutics AB's OCF Yield % too high?
Elicera Therapeutics AB's current OCF Yield % is -15.06. Based on the distribution chart, Elicera Therapeutics AB ranks #893 out of 1410 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Elicera Therapeutics AB has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Elicera Therapeutics AB's OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Elicera Therapeutics AB ranks #893 out of 1410 companies for OCF Yield %. This places Elicera Therapeutics AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Elicera Therapeutics AB and its competitors. Elicera Therapeutics AB's current OCF Yield % is -15.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elicera Therapeutics AB stock overvalued right now?
Elicera Therapeutics AB (FRA:8E8) has a current OCF Yield % of -15.06. The current OCF Yield % is -15.06. Elicera Therapeutics AB's overall GF Score™ is 40/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Elicera Therapeutics AB (FRA:8E8), the current OCF Yield % is -15.06 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Elicera Therapeutics AB Business Description

Other Exchanges ELIC:Sweden
Address Massans gata 10, World Trade Center Goteborg, 7th Floor, Goteborg, SWE, 412 51
Elicera Therapeutics AB is a Sweden-based clinical-stage immuno-oncology company developing cell and gene therapies for immune-based cancer treatments. Its product portfolio consists of four drug candidates, including two in the field of oncolytic viruses (ELC-100 and ELC-201) and two in the field of CAR T-cell treatments (ELC-301 and ELC-401), in addition to the universal CAR T-cell technology platform, iTANK (ELC-001). The Company is running four internal immunotherapy development projects, comprising two CAR T-cell programs and two oncolytic virus programs.
40GF Score

Get the complete analysis for FRA:8E8

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.21
Price